Qualigen Therapeutics EV - Enterprise Value 2011-2026 | QLGN

Annual EV - Enterprise Value Qualigen Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-19.3 M	58.4 K	-55.8 K	7.12 M	-9.33 M	83.2 M	44.4 M	1.36 M	-12.7 M	25.9 M	-10.4 M	-2.75 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
83.2 M	-19.3 M	8.95 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
BioLineRx Ltd. BLRX	15 M	$ 2.25	1.81 %	$ 908 M	Israel
BioNTech SE BNTX	-4.91 B	$ 91.28	0.11 %	$ 27.2 B	Germany
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Alnylam Pharmaceuticals ALNY	43.3 B	$ 330.34	3.6 %	$ 43.3 B	USA
CollPlant Biotechnologies Ltd. CLGN	169 M	$ 0.44	-16.64 %	$ 5.04 M	Israel
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Catalyst Pharmaceuticals CPRX	2.48 B	$ 24.98	1.17 %	$ 3.05 B	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Corbus Pharmaceuticals Holdings CRBP	119 M	$ 10.14	-0.29 %	$ 135 M	USA
Cardiff Oncology CRDF	115 M	$ 1.58	-	$ 106 M	USA
Curis CRIS	18.9 M	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	4.14 B	$ 37.7	1.26 %	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	4.38 B	$ 49.15	-0.73 %	$ 4.42 B	Schweiz
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Anavex Life Sciences Corp. AVXL	197 M	$ 2.96	-1.0 %	$ 252 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CytomX Therapeutics CTMX	971 M	$ 4.4	-3.51 %	$ 607 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Citius Pharmaceuticals CTXR	63.5 M	$ 0.86	0.67 %	$ 5.79 M	USA
Cue Biopharma CUE	18 M	$ 0.18	-1.61 %	$ 17.1 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.09	-0.97 %	$ 437 M	USA
Cyclerion Therapeutics CYCN	3.31 M	$ 4.15	-32.52 %	$ 10.4 M	USA
Daré Bioscience DARE	21.8 M	$ 1.81	4.02 %	$ 20.2 M	USA
DBV Technologies S.A. DBVT	2.69 B	$ 20.36	-3.32 %	$ 2.84 B	France
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	43.4 M	$ 8.22	2.37 %	$ 225 M	Israel
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Denali Therapeutics DNLI	3.01 B	$ 19.38	-6.15 %	$ 3.19 B	USA
Dyadic International DYAI	35.6 M	$ 0.87	-2.8 %	$ 31.5 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	2.07 B	$ 31.37	1.0 %	$ 2.08 B	USA
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA